Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Development and validation of UPLC method for quantitative estimation of related impurities in tizanidine hydrochloride tablets

Sanjay Shesha Shetgar, Ramadevi Dharmasoth, Basavaiah Keloth, Bandlamudi Mallikarjuna Rao.




Abstract
Cited by 1 Articles

Tizanidine hydrochloride is known to have several related impurities depending on the manufacturing process. There is no published ultra-performance liquid chromatography (UPLC) method which can simultaneously quantify these impurities. The current work is to design, develop, and validate an UPLC method for simultaneous estimation of all known impurities. Forced degradation studies performed on tablet formulation did not show any purity flags. To achieve sensitive and optimal separation of all the six impurities from the main moiety of Tizanidine, gradient UPLC system with ethylene bridged hybrid C8 column, 230 nm UV detection provided an optimum separation. The developed method was quick, with all six impurities eluting within 11 minutes. Low level of impurities could be quantified with limit of detection in the range 0.008%–0.028% and limit of quantitation in the range 0.037%–0.057%. Recoveries of all spiked impurities in Tizanidine hydrochloride were well within the range of 85%–115%. Thus, the developed UPLC method is sensitive, fast, and provides precise and accurate quantitation of all known impurities in Tizanidine hydrochloride tablets. The developed method is very useful for quantitative estimation of impurities in Tizanidine hydrochloride tablets in routine quality control as well as stability monitoring programs. The method can easily be extended to quantitative cleaning residue determination in pharmaceutical industry.

Key words: Quantitative, Impurity, LOD, LOQ, Tizanidine, UPLC






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.